Clinical Trial Update: A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis [Phase 2]

View source ↗

Summary

Results from a Phase 2a study evaluating ABT-981 in erosive hand osteoarthritis have been posted, detailing safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Hand Osteoarthritis

Drugs mentioned

• ABT-981 (ABT-981)

Snippet

Sponsor: AbbVie | Conditions: Erosive Hand Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2017-07-13